Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Genetic Characterization of Movement Disorders and Dementias

View source ↗

Summary

This study aims to genetically characterize movement disorders and dementias and is currently recruiting under the National Institute on Aging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Dementia, Movement Disorder | Status: RECRUITING